Bigul

Announces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated) & Results Press Release for the Quarter ended June 30, 2016

Fortis Healthcare Ltd has announced the following results for the quarter ended June 30, 2016:The Unaudited Standalone results for the Quarter ended June 30, 2016The Company has posted a net loss of Rs. (70.50) million for the quarter ended June 30, 2016 as compared to net loss of Rs. (193.10) million for the quarter ended June 30, 2015. Total Income has increased from Rs. 1961.10 million for the quarter ended June 30, 2015 to Rs....
04-08-2016
Bigul

Fortis Healthcare arm hikes stake in Lalitha Healthcare

Fortis Healthcare today said its arm Fortis Cancer Care has increased stake in group firm Lalitha Healthcare, thereby taking its overall holding to 79.43 per cent. Fortis Cancer Care Ltd (FCCL) has i...
03-08-2016
Bigul

Updates

Fortis Healthcare Ltd has informed BSE that one of Company's stepdown subsidiary company viz Fortis Cancer Care Limited has informed the Company that it has increased its shareholding in Lalitha Healthcare Private Limited (Lalitha) by 98972 equity shares (i.e. 12.2% of total share capital of Lalitha) of Rs. 10 each.
03-08-2016
Bigul

Updates

With reference to earlier letter dated June 10, 2016 wherein the Company has informed that one of subsidiary viz. Escort Heart Institute & Research Centre Limited (EHIRCL) had received an order dated June 09, 2016 ("Order") from Directorate General of Health Services ("DGHS") for the recovery of Rs. 503,36,52,824/- (Rupees Five Hundred & Three Crores, Thirty Six Lac, Fifty-Two Thousand Eight Hundred and Twenty Four only) on account of alleged unwarranted...
02-08-2016
Bigul

Updates on ensuing Board Meeting on August 04, 2016

With reference to the earlier letter dated July 27, 2016 regarding the notice of meeting of the Board of Directors of the Company scheduled to be held on August 04, 2016, inter alia, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2016 (Q1).Fortis Healthcare Ltd has now informed BSE that the Board shall also be considering an enabling fund raising option including but not limited to qualified institutions...
01-08-2016
Bigul

Q1 results on August 04, 2016

Fortis Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 04, 2016, inter alia, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2016 (Q1).Further, the trading window of the Company for dealing in securities of the Company will remain closed from July 28, 2016 to August 06, 2016 (both days inclusive).
27-07-2016
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

International Finance Corporation FDI has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25-07-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Fortis Healthcare Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
22-07-2016
Bigul

Clarifies on news item

With reference to the news in CNBC TV18 "Fortis set to demerge SRL Diagnostic in a separate entity in next 2-3 weeks.", Fortis Healthcare Ltd has submitted to BSE a copy of Clarification is enclosed.
20-07-2016
Bigul

Clarification sought from Fortis Healthcare Ltd

The Exchange has sought clarification from Fortis Healthcare Ltd with reference to the news in CNBC TV18 "Fortis set to demerge SRL Diagnostic in a separate entity in next 2-3 weeks." The reply is awaited.
20-07-2016
Next Page
Close

Let's Open Free Demat Account